- Home
- ACIU vs CURR Comparison
ACIU vs CURR Comparison
Compare ACIU & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | CURR |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | Switzerland | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 224.4M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | CURR |
|---|---|---|
| Price | $3.68 | $1.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $10.00 | $3.50 |
| AVG Volume (30 Days) | ★ 1.5M | 263.7K |
| Earning Date | 11-04-2025 | 11-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,482,957.00 | ★ $40,227,053.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $644.42 | $14.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $0.33 |
| 52 Week High | $4.00 | $7.08 |
Technical Indicators
Market Signals| Indicator | ACIU | CURR |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 39.58 |
| Support Level | $3.09 | $1.61 |
| Resistance Level | $3.73 | $2.03 |
| Average True Range (ATR) | 0.21 | 0.16 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 91.86 | 29.55 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.